Search Results - "Kurita, Masatake"
-
1
Plasma brain-derived neurotrophic factor levels predict the clinical outcome of depression treatment in a naturalistic study
Published in PloS one (27-06-2012)“…Remission is the primary goal of treatment for major depressive disorder (MDD). However, some patients do not respond to treatment. The main purpose of this…”
Get full text
Journal Article -
2
The noradrenaline metabolite MHPG is a candidate biomarker from the manic to the remission state in bipolar disorder I: a clinical naturalistic study
Published in PloS one (27-06-2014)“…Remission is the primary goal of treatment for bipolar disorder I (BDI). Metabolites of noradrenaline and dopamine, 3-methoxy-4-hydroxyphenylglycol (MHPG) and…”
Get full text
Journal Article -
3
The noradrenaline metabolite MHPG is a candidate biomarker between the depressive, remission, and manic states in bipolar disorder I: two long-term naturalistic case reports
Published in Neuropsychiatric disease and treatment (01-01-2015)“…Treatment of the depressive and manic states in bipolar disorder I (BDI) is a challenge for psychiatrists. Despite the recognized importance of the switch…”
Get full text
Journal Article -
4
Noradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episode
Published in Neuropsychiatric disease and treatment (01-01-2016)“…Although antidepressants may increase the risk of switching to mania in bipolar disorder (BD), clinicians have been using antidepressants to treat patients…”
Get full text
Journal Article -
5
Brain-derived neurotrophic factor (BDNF)
Published in Nihon rinshō (01-07-2010)Get more information
Journal Article -
6
Efficacy and Tolerability of Risperidone, Yokukansan, and Fluvoxamine for the Treatment of Behavioral and Psychological Symptoms of Dementia: A Blinded, Randomized Trial
Published in Journal of clinical psychopharmacology (01-10-2013)“…The descriptive term behavioral and psychological symptoms of dementia (BPSD) is used to cover a range of noncognitive disturbances including anxiety,…”
Get full text
Journal Article -
7
Entrainment of the Circadian Clock in Neural Stem Cells by Epidermal Growth Factor is Closely Associated with ERK1/2-mediated Induction of Multiple Clock-related Genes
Published in Neuroscience (21-05-2018)“…•EGF causes the phase-resetting of molecular circadian clock in the neural stem cells.•EGF acutely and transiently induces the expression of multiple…”
Get full text
Journal Article -
8
Case of bipolar disorder successfully stabilized with clonazepam, valproate and lithium after numerous relapses for 47 years
Published in Psychiatry and clinical neurosciences (01-06-2004)Get full text
Journal Article -
9
EFFECTS OF FLUVOXAMINE ON BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA IN ALZHEIMER'S DISEASE : A REPORT OF THREE CASES
Published in FUKUSHIMA JOURNAL OF MEDICAL SCIENCE (2006)“…OBJECTIVE : To report 3 cases of severe behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease (AD) with fluvoxamine treatment and to…”
Get full text
Journal Article -
10
Divergent effects of lithium and sodium valproate on brain-derived neurotrophic factor (BDNF) production in human astrocytoma cells at therapeutic concentrations
Published in Progress in neuro-psychopharmacology & biological psychiatry (01-10-2012)“…Mood stabilizers such as lithium (Li) or valproic acid (VPA) are used in the therapy of bipolar disorders, but the mechanisms by which these medicines work is…”
Get full text
Journal Article -
11
The presence of thromboxane A2 receptors in cultured astrocytes from rabbit brain
Published in Brain research (26-06-1992)“…We have previously shown that human astrocytoma cells (1321N1) express thromboxane A2 (TXA2) receptors, of which stimulation activates phosphoinositide…”
Get more information
Journal Article -
12
Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function
Published in Neuropsychiatric disease and treatment (01-01-2016)“…Although three drugs, risperidone, yokukansan, and fluvoxamine, have shown equal efficacy in treating behavioral and psychological symptoms of dementia (BPSD)…”
Get full text
Journal Article -
13
Need for medication to complement catecholamines in smoking cessation of hardcore smokers
Published in Neuropsychiatric disease and treatment (01-01-2017)“…Many smokers find it difficult to stop smoking without assistance. The antidepressants bupropion and nortriptyline can aid smoking cessation. The main aim of…”
Get full text
Journal Article -
14
Non-24-hour sleep-wake syndrome improved by low-dose valproic acid: a case report
Published in Neuropsychiatric disease and treatment (01-01-2016)“…A woman was diagnosed with non-24-hour sleep-wake syndrome and depressive symptoms. Her depressive symptoms did not respond to standard doses of several…”
Get full text
Journal Article -
15
Sodium valproate at therapeutic concentrations changes Ca2+response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells
Published in Progress in neuro-psychopharmacology & biological psychiatry (13-04-2007)“…Sodium valproate (VPA) has been used clinically for treatment of not only epilepsy but also mood disorder. Although VPA is effective for treatment of epilepsy…”
Get full text
Journal Article -
16
Sodium valproate at therapeutic concentrations changes Ca super(2+)response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells
Published in Progress in neuro-psychopharmacology & biological psychiatry (01-04-2007)“…Sodium valproate (VPA) has been used clinically for treatment of not only epilepsy but also mood disorder. Although VPA is effective for treatment of epilepsy…”
Get full text
Journal Article -
17
Sodium valproate at therapeutic concentrations changes Ca 2+response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells
Published in Progress in neuro-psychopharmacology & biological psychiatry (2007)“…Sodium valproate (VPA) has been used clinically for treatment of not only epilepsy but also mood disorder. Although VPA is effective for treatment of epilepsy…”
Get full text
Journal Article -
18
Lithium chloride at a therapeutic concentration reduces Ca 2+ response in protein kinase C down-regulated human astrocytoma cells
Published in European journal of pharmacology (2002)“…Since the therapeutic efficacy of Li + in the treatment of mood disorder is observed only after chronic administration, we examined whether long-term Li +…”
Get full text
Journal Article -
19
Lithium chloride at a therapeutic concentration reduces Ca2+response in protein kinase C down-regulated human astrocytoma cells
Published in European journal of pharmacology (03-05-2002)“…Since the therapeutic efficacy of Li+ in the treatment of mood disorder is observed only after chronic administration, we examined whether long-term Li+…”
Get full text
Journal Article -
20
Discrimination Of Histamine H 1 and Muscarinic Receptor‐Mediated Signalling Pathways By Phorbol Ester In Human Astrocytoma Cells
Published in Clinical and experimental pharmacology & physiology (11-03-2000)“…1. Histamine H 1 receptor‐mediated signalling was compared with muscarinic receptor‐mediated signalling in 1321N1 human astrocytoma cells. 2. Short‐term (2…”
Get full text
Journal Article